Notably, miR-7 was found to be elevated approximately 2-fold in sera from NSCLC patients compared to the control counterparts [41], which is contradictory to the observation that over-expression of miR-7 suppressed EGFR and induced sensitizing response to gefitinib in vitro [21]. Here, EGFR is linked to non-small cell lung carcinoma.